Pharma
-
ASBP: Unlocking Multi-Billion Dollar Markets with Enhanced Drug Delivery
Enter Aspire Biopharma, Inc. (NASDAQ: ASBP), a pioneering company enhancing existing drugs with their patent-pending, soluble sublingual technology. By delivering…
Read More » -
Aspire Biopharma CEO Interview: Disrupting Drug Delivery with Sublingual Tech
SmallCaps Daily sits down with ASBP’s CEO Kraig Higginson to discuss the company's disruptive technology and the expected clinical and…
Read More » -
NanoViricides Recent Clinical Updates and Milestones Highlight Potential Investor Opportunities
NanoViricides, Inc. (NYSE American: NNVC), a pioneering, clinical-stage biopharmaceutical company, is disrupting the antiviral game with its innovative, first-in-class, nanoviricides®…
Read More » -
Decoded: Why Did Johnson & Johnson Spend $2 billion To Acquire Ambrx Biopharma?
In a groundbreaking move, pharmaceutical giant Johnson & Johnson has set the stage for a significant leap forward in cancer…
Read More » -
TG Therapeutics: Is It Time to Invest In This Biotech Player After The Unprecedented 36.4% Jump?
TG Therapeutics' stock soared an astonishing 36.4% higher in a single session on the heels of the company's impressive third-quarter…
Read More » -
OKYO Pharma: An Emerging Biopharma With Game Changing Treatments In Ophthalmology
OKYO Pharma's main drug has already surpassed Phase 1 and reached Phase 2. OK-101 is catering to niches within the…
Read More » -
NanoViricides Gets Big Funding Boost From CEO Dr. Anil Diwan Prior To IND Application
Based in Connecticut, NanoViricides is a growth stage firm that’s at superior levels of trials with respect to a number…
Read More » -
NanoViricides: Grab This Biopharma Player While Inexpensive
Investment timing is among the most important ideas associated to the world of stock market investing. While its software is…
Read More » -
NanoKnife FDA Approval Is The Highlight Of An Otherwise Tepid AngioDynamics Quarter
Latham, New York: AngioDynamics, Inc. (NASDAQ:ANGO) is a number one supplier of modern, minimally invasive medical units utilized by skilled…
Read More » -
Lexicon’s Volatility Could Be Your Friend After The Zynquista Rejection
Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX) is an organization identified for locating novel drug targets and drug candidates developed from state-of-the-art medicinal…
Read More »
